Multicenter comparative evaluation of six commercial systems and the national committee for clinical laboratory standards m27-a broth microdilution method for fluconazole susceptibility testing of Candida species

Multicenter comparative evaluation of six commercial systems and the national committee for clinical laboratory standards m27-a broth microdilution method for fluconazole susceptibility testing of Candida species

Item

http://www.wikidata.org/entity/Q33964454

Q33964454

about

Comparison of results of fluconazole disk diffusion testing for Candida species with results from a central reference laboratory in the ARTEMIS global antifungal surveillance program.Evaluation of the Etest and disk diffusion methods for determining susceptibilities of 235 bloodstream isolates of Candida glabrata to fluconazole and voriconazole Candidal colonization, strain diversity, and antifungal susceptibility among adult diabetic patients.Antifungal susceptibility of invasive yeast isolates in Italy: the GISIA3 study in critically ill patients.Comparison of two probes for testing susceptibilities of pathogenic yeasts to voriconazole, itraconazole, and caspofungin by flow cytometry Comparative evaluation of the Vitek 2 yeast susceptibility test and CLSI broth microdilution reference method for testing antifungal susceptibility of invasive fungal isolates in Italy: the GISIA3 study In vitro susceptibility testing of Geotrichum capitatum: comparison of the E-test, disk diffusion, and Sensititre colorimetric methods with the NCCLS M27-A2 broth microdilution reference method.Evaluation of Etest method for determining fluconazole and voriconazole MICs for 279 clinical isolates of Candida species infrequently isolated from blood Multicenter comparison of the VITEK 2 yeast susceptibility test with the CLSI broth microdilution reference method for testing fluconazole against Candida spp.Fluconazole for the treatment of candidiasis: 15 years experience.Comparison of two microdilution methods for testing susceptibility of Candida spp. to voriconazole.Multicenter comparison of the VITEK 2 antifungal susceptibility test with the CLSI broth microdilution reference method for testing amphotericin B, flucytosine, and voriconazole against Candida spp Antifungal susceptibility testing by flow cytometry: is it the future?Clinical evaluation of the Sensititre YeastOne colorimetric antifungal plate for antifungal susceptibility testing of the new triazoles voriconazole, posaconazole, and ravuconazole.The current role of the reference procedures by CLSI and EUCAST in the detection of resistance to antifungal agents in vitro.Comparison of species-level identification and antifungal susceptibility results from diagnostic and reference laboratories for bloodstream Candida surveillance isolates, South Africa, 2009-2010.Clinical evaluation of the Sensititre YeastOne colorimetric antifungal panel for antifungal susceptibility testing of the echinocandins anidulafungin, caspofungin, and micafungin.Selection of a surrogate agent (fluconazole or voriconazole) for initial susceptibility testing of posaconazole against Candida spp.: results from a global antifungal surveillance program.Comparison of visual 24-hour and spectrophotometric 48-hour MICs to CLSI reference microdilution MICs of fluconazole, itraconazole, posaconazole, and voriconazole for Candida spp.: a collaborative study.Susceptibility to antifungal agents of Candida species isolated from paediatric and adult patients with haematological diseases.Antifungal susceptibility of bloodstream yeasts isolated at a public children's hospital in Brazil: comparison of the Etest and the AFST-EUCAST microdilution method.In vitro activity of a monoclonal killer anti-idiotypic antibody and a synthetic killer peptide against oral isolates of Candida spp. differently susceptible to conventional antifungals.

P2860

Q30449026-2C4A3E43-B765-4270-9B94-6A13F02E0705 Q30452973-E5CFC3AB-8EC7-4DCC-B65A-E0A3720472A1 Q33791239-01BDA952-E581-4F51-B146-39B1AC5A3214 Q33903375-1E04AA54-A768-404C-B2BA-148873CC93C8 Q34042198-EBB26F0E-3722-45A2-9CDD-7DC7462D4DCB Q34120336-8F5F7B4B-C091-420B-A15B-4FBAC2FF4F0B Q34231270-1517A1EC-4F09-4897-A829-381E5934523B Q34774859-EDA23D9F-05EC-47AA-99CA-7DEA8EB8CFE7 Q35690728-99244C1A-32A4-41B0-9592-AA36468BEBC1 Q35917407-5FC66D20-2050-4FF0-8F45-6E4E9B80EC94 Q36240476-9C0D0A3E-CF4E-4C2C-A79E-9134C5AF5878 Q36314322-2C8163D2-28AC-4554-A41C-150472011557 Q36511353-539CC411-1E6C-494B-B517-776A01691EE7 Q37576369-345481B8-384A-4855-AE5D-75EB286A3E0A Q37700546-7A8608FD-45DF-4C11-9DE8-B6CA5F3533C6 Q39290985-CA6F10CA-B5BF-4AA5-B75E-80317E315D29 Q39763435-FC486C36-1911-496D-89C2-7F6C5B3A3B8C Q42078949-34373E9A-4732-4719-9C69-8B70700ED7F9 Q42249573-D4B9691C-3904-4929-B369-3213DF297932 Q46785730-47BAAF0B-F2DA-4699-AFFF-CEE7B7FFF082 Q46865944-D5026953-239D-4D14-BAE6-67B76AD81D46 Q51440264-F5285E8D-839D-48C4-B07D-F87CD25764A8

P2860

Multicenter comparative evaluation of six commercial systems and the national committee for clinical laboratory standards m27-a broth microdilution method for fluconazole susceptibility testing of Candida species

Item

http://www.wikidata.org/entity/Q33964454

description

2002 nî lūn-bûn

@nan

2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu